주메뉴 닫기
주메뉴 닫기
Home About Us COMPANY HISTORY

COMPANY HISTORY

COMPANY HISTORY


  • 2019 - 2022

  • 2017 - 2018

  • 2012 - 2016

  • 2000 - 2011
Leaping into a World-Class Biotech Company Engaging in Drug Development2019-2022
  • Plans to initiate Phase II/III clinical trials to test CP-COV03 were approved.
  • The company signed an agreement for the production of CP-COV03
         with Dongkook Pharmaceutical.
  • The company signed a contract for exclusive sales and
         marketing of ‘Vitabrid’ in Korea with CMG Pharmaceutical.
  • Plans to initiate Phase Iclinical trials to test CP-COV03 were approved.
  • The company signed an agreement for the production of CP-COV03
         with YOOYOUNG Pharmaceutical.
  • HYUNDAI BIOSCIENCE went out of the IT business in order to focus
         on the biotechnology business
Leaping into a World-Class Biotech Company Engaging in Drug Development2017-2018
  • The companyobtained a quasi-drugs approval for Vitabrid C12 HAIR.
  • A biomanufacturing facility in Gimcheon, Gyeongsangbuk-do was expanded.
  • A contract for exclusive supply of Vitabrid in Russia was signed.
  • An agreement for the establishment of joint ventures in the Middle East and
    North America was signed     
  • The brand was launched exclusively at 11 Barneys New York stores and
    became the first Korean brand to be launched at Barneys New York     
  • ‘PEPTIBRID’, a new biomaterial,
    was added to the International Cosmetic IngredientDictionary     
  • The company developed a drug delivery system for anti-inflammatory collyrium,
    which is normally taken after cataract surgery, and began clinical trials to test it     
    (in collaboration with Kolmar Korea and ChemOn)     
  • The company changed its name to HYUNDAI BIOSCIENCE.
Results of Research and Development2012-2016
  • Vitabrid C12 HAIR was selected as one of the 100 Korea’s Inno Stars by KMA.
  • Vitabrid C12 SKIN received the “Grand Gold Prize” in cosmetics at 2016 Monde Selection.
  • Vitabrid C12 received an award at the Cosmoprof Las Vegas Beauty Trade Show.
  • Vitabrid C12 was selected as the 2016 innovative brand by BEAUTYSTREAMS.
  • The company changed its name from HYUNDAI IT to HYUNDAI BIOSCIENCE.
  • The company built a biomanufacturing facility in Gincheon.
  • HYUNDAI IBT and EwhaWomens University formed a joint bio-fusion research group.
  • Vitabrid C12 was released in Korea.
Establishment of the Company and Entering the Biotech Industry2000-2011
  • The company was listed on the Nasdaq stock market.
  • The company was awarded with the $300 Million
    Export Tower on the 41stNational Trade Day.     
  • The company changed its name to HYUNDAI IT.